LEADER 02996nam 2200661 a 450 001 9910459683503321 005 20200520144314.0 010 $a988-220-675-1 010 $a1-282-70875-9 010 $a9786612708756 010 $a988-8052-13-6 035 $a(CKB)2670000000039474 035 $a(EBL)3011738 035 $a(SSID)ssj0000414336 035 $a(PQKBManifestationID)11263143 035 $a(PQKBTitleCode)TC0000414336 035 $a(PQKBWorkID)10401389 035 $a(PQKB)11561252 035 $a(StDuBDS)EDZ0000035470 035 $a(MiAaPQ)EBC3011738 035 $a(OCoLC)650586929 035 $a(MdBmJHUP)muse7138 035 $a(Au-PeEL)EBL3011738 035 $a(CaPaEBR)ebr10453700 035 $a(CaONFJC)MIL270875 035 $a(OCoLC)923635120 035 $a(EXLCZ)992670000000039474 100 $a20100223d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCollaborative colonial power$b[electronic resource] $ethe making of the Hong Kong Chinese /$fLaw Wing Sang 210 $aHong Kong $cHong Kong University Press ;$aLondon $cEurospan [distributor]$d2009 215 $a1 online resource (277 p.) 225 1 $aHong Kong culture and society 300 $aDescription based upon print version of record. 311 $a962-209-930-0 311 $a962-209-929-7 320 $aIncludes bibliographical references and index. 327 $a""Contents""; ""Series Foreword""; ""Acknowledgements""; ""Introduction: Coloniality and Hong Kong Chineseness""; ""I - Collaboration and Institutions""; ""1 - Social Fabric of a Collaborative Colonialism""; ""2 - Cultural Coloniality: The English Language and Schooling""; ""3 - Pedagogy of Imperialism: Indirect Rule and HKU""; ""II - Hong Kong In-Betweens""; ""4 - Double Identity of the Colonial Intelligentsia: Ho Kai""; ""5 - Chinese Cultural Nationalism and Southern Localism""; ""6 - Cultural Cold War and the Diasporic Nation""; ""III - Lingering Colonialism"" 327 $a""7 - Indigenizing Colonial Power and the Return to China""""8 - Northbound Colonialism: Reinventing Hong Kong Chinese""; ""Conclusion: Re-theorizing Colonial Power""; ""Character List""; ""Notes""; ""Bibliography""; ""Index"" 330 8 $aThe contents of this work cover the social fabric of a collaborative colonialism, Chinese cultural nationalism and southern localism, cultural Cold War and the disaporic nation and much more. 410 0$aHong Kong culture and society. 607 $aHong Kong (China)$xColonial influence 607 $aHong Kong (China)$xCivilization 607 $aHong Kong (China)$xPolitics and government 608 $aElectronic books. 676 $a951.25 700 $aLaw$b Wing Sang$01037273 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910459683503321 996 $aCollaborative colonial power$92458125 997 $aUNINA LEADER 06711nam 22006972 450 001 9910785495303321 005 20151005020621.0 010 $a1-107-21867-5 010 $a0-511-85175-8 010 $a1-282-91852-4 010 $a9786612918520 010 $a0-511-91806-2 010 $a0-511-78086-9 010 $a0-511-91527-6 010 $a0-511-91904-2 010 $a0-511-91348-6 010 $a0-511-91708-2 035 $a(CKB)2670000000057925 035 $a(EBL)585303 035 $a(OCoLC)689996445 035 $a(SSID)ssj0000434099 035 $a(PQKBManifestationID)11300703 035 $a(PQKBTitleCode)TC0000434099 035 $a(PQKBWorkID)10396248 035 $a(PQKB)11546369 035 $a(UkCbUP)CR9780511780868 035 $a(MiAaPQ)EBC585303 035 $a(Au-PeEL)EBL585303 035 $a(CaPaEBR)ebr10433594 035 $a(CaONFJC)MIL291852 035 $a(PPN)261338129 035 $a(EXLCZ)992670000000057925 100 $a20100519d2011|||| uy| 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aCancer symptom science $emeasurement, mechanisms, and management /$fedited by Charles S. Cleeland, Michael J. Fisch [and] Adrian Dunn$b[electronic resource] 210 1$aCambridge :$cCambridge University Press,$d2011. 215 $a1 online resource (xvii, 356 pages) $cdigital, PDF file(s) 225 0 $aCambridge medicine Cancer symptom science 300 $aTitle from publisher's bibliographic system (viewed on 05 Oct 2015). 311 $a0-521-86901-3 320 $aIncludes bibliographical references and index. 327 $aMachine generated contents note: Preface; Foreword; Part I. Introduction: 1. Introduction to Cancer Symptom Science Charles S. Cleeland, Adrian J. Dunn and Michael J. Fisch; 2. Researching the mechanisms underlying the symptoms of patients with cancer Adrian J. Dunn; 3. Cytokines, sickness behavior: a model for cancer symptoms Steven S. Zalcman, Randall T. Woodruff, Ruchika Mohla and Allan Siegal; Part II. Cancer Symptom Mechanisms and Models: Clinical and Basic Science: 4. The clinical science of cancer pain assessment and management Russell K. Portenoy and Victor T. Chang; 5. Pain: basic science: 5a. Mechanisms of disease-related pain in cancer: insights from the study of bone tumors Patrick W. Mantyh and Juan Miguel Jimenez Andrade; 5b. Neuropathic pain: basic science Patrick M. Dougherty and Haijun Zhang; 6. Cognitive dysfunction: is chemobrain real? Christina A. Meyers and Jeffrey S. Wefel; 7. Cognitive impairment: basic science Perry N. Fuchs, Jessica A. Boyette-Davis and Adrian J. Dunn; 8. Depression in cancer: pathophysiology at the mind-body interface Andrew H. Miller, Michael A. Burke and Charles L. Raison; 9. Depressive illness: basic science: 9a. Animal models of depressed mood and sickness behavior Adrian J. Dunn; 9b. From inflammation to sickness and depression: the cytokine connection Robert Dantzer and Keith W. Kelly; 10. Cancer-related fatigue: clinical science Xin Shelley Wang; 11. Developing translational animal models of cancer-related fatigue Mary W. Meagher; 12. Cancer anorexia/weight loss syndrome Aminah Jatoi and Nisha Lassi; 13. Appetite loss/cachexia: basic science Tristin D. Brisbois-Clarkson, Wendy V. Wismer and Vickie E. Baracos; 14. Sleep and its disorders: clinical science Sofia Ancoli-Israel and Lianqi Liu; 15. Sleep and its disorders Mark R. Opp and Luca Imeri; 16. Proteins and symptoms Bang-Ning Lee and James M. Reuben; 17. Genetic approaches to treating and preventing symptoms in patients with cancer Quiling Shi and Charles S. Cleeland; 18. Functional imaging of symptoms T. Dorina Papageorgiou, Edward F. Jackson and Javier O. Valenzuela; 19. High-dose therapy and posttransplantation symptom burden: striking a balance Sergio A. Giralt and Loretta A. Williams; Part III. Clinical Perspectives in Symptom Management and Research: 20. Promoting symptom research in cooperative groups Lynne I. Wagner and David Cella; 21. Practical aspects of symptom management in patients with cancer Richard T. Lee and Michael J. Fisch; Part IV. Symptom Measurement: 22. Symptom measurement by patient report Charles S. Cleeland and Tito R. Mendoza; 23. The economics of cancer-related symptoms: valuing supportive care interventions Lesley-Ann Miller and Jane C. Weeks; 24. Longitudinal models for symptoms Diane L. Fairclough; 25. Bayesian adaptive design: a new approach to test the effectiveness of symptom-reducing agents using patient-reported outcomes Valen E. Johnson and Tito R. Mendoza; Part V. Government and Industry Perspectives: 26. Promoting cancer symptom science research Ann O'Mara and Maria Sgambati; 27. Developing symptom management drugs Joanna M. Brell and Lori M. Minasian; 28. Cancer-related symptoms: issues for consideration in drug and therapeutic biological product label claims in the United States Jane A. Scott; 29. Symptom research: looking ahead Charles S. Cleeland, Adrian J. Dunn and Michael J. Fisch; Index. 330 $aCancer Symptom Science is the first interdisciplinary compilation of research on the mechanisms underlying the expression of cancer-related symptoms. It presents innovations in clinical, animal and in vitro research, research methods in brain imaging, and statistical-descriptive approaches to understanding the mechanistic basis of symptom expression. This volume also provides perspectives from patients, government and industry. By collecting and synthesizing the developing threads of new approaches to understanding cancer-related symptoms, the book promotes a pioneering framework for merging behavioral and biological disciplines to clarify mechanisms of symptom evolution, incorporating new technologies, testing novel agents for symptom control, and improving patient functioning and quality of life both during and after cancer treatment. With an expert editorial team led by Charles S. Cleeland, an internationally-recognized leader in cancer pain assessment and treatment, this is essential reading for surgical, clinical and medical oncologists, academic researchers, and pharmaceutical companies developing new agents to control symptom expression. 606 $aCancer$xPathophysiology 606 $aSymptoms 615 0$aCancer$xPathophysiology. 615 0$aSymptoms. 676 $a616.99/4071 702 $aCleeland$b Charles S. 702 $aFisch$b Michael J.$f1964- 702 $aDunn$b Adrian J. 801 0$bUkCbUP 801 1$bUkCbUP 906 $aBOOK 912 $a9910785495303321 996 $aCancer symptom science$93829291 997 $aUNINA